Phospho-PKC (pan) (gamma Thr514) Antibody

Phospho-PKC (pan) (gamma Thr51

4) Antibody
收藏
  • 询价
  • Cell Signaling Technology已认证
  • USA
  • 2025年10月21日
  • W, IP
  • Rabbit
  • H,M,R,Mk
avatar
品牌商
12钻石会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 技术资料
    • 抗体英文名

      Phospho-PKC (pan) (gamma Thr514) Antibody

    • 抗原

      synthetic phosphopeptide corresponding to residues surrounding Thr514 of human PKCgamma

    • 应用范围

      W, IP

    • 宿主

      Rabbit

    • 库存

      大量

    • 保质期

      详见说明书

    • 供应商

      CST

    • 级别

      详见MSDS文件

    • 适应物种

      H,M,R,Mk

    • 是否单克隆

      2

    • 保存条件

      -20°c

    • 规格

      100 ul (10 western blots)/carrier free & custom formulation / quantity

    规格:产品价格:¥请询价
    规格:100 ul (10 western blots)产品价格:¥请询价
    规格:carrier free & custom formulation / quantity产品价格:¥请询价

    pathway more info application references datasheet PDF MSDS PDF protocols

    Applications Key:  W=Western Blotting  IP=Immunoprecipitation
    Reactivity Key:  H=Human  M=Mouse  R=Rat  Mk=Monkey
    Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.

    Applications Reactivity Sensitivity MW (kDa) Source
    W IP H M R Mk Endogenous 78, 80, 82, 85 Rabbit
    Protocols
    Specificity / Sensitivity

    Phospho-PKC (pan) (gamma Thr514) Antibody detects endogenous levels of PKC alpha, beta I, beta II, gamma, delta, epsilon, eta and theta isoforms only when phosphorylated at a residue homologous to threonine 514 of human PKCgamma. This antibody does not detect PKC phosphorylated at other sites.

    Source / Purification

    Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Thr514 of human PKCgamma. Antibodies are purified by protein A and peptide affinity chromatography.

    Western Blotting

    Western Blotting

    Western blot analysis of extracts from U937, C6 and HeLa cells, untreated, TPA-treated, or lambda phosphatase-treated as indicated, using Phospho-PKC (pan) (gamma Thr514) Antibody.

    Western Blotting

    Western Blotting

    Western blot analysis of Baculovirus-expressed PKC isofroms, using Phospho-PKC (pan) (gamma Thr514) Antibody.

    Background

    Activation of protein kinase C (PKC) is one of the earliest events in a cascade that controls a variety of cellular responses, including secretion, gene expression, proliferation, and muscle contraction (1,2). PKC isoforms belong to three groups based on calcium dependency and activators. Classical PKCs are calcium-dependent via their C2 domains and are activated by phosphatidylserine (PS), diacylglycerol (DAG), and phorbol esters (TPA, PMA) through their cysteine-rich C1 domains. Both novel and atypical PKCs are calcium-independent, but only novel PKCs are activated by PS, DAG, and phorbol esters (3-5). Members of these three PKC groups contain a pseudo-substrate or autoinhibitory domain that binds to substrate-binding sites in the catalytic domain to prevent activation in the absence of cofactors or activators. Control of PKC activity is regulated through three distinct phosphorylation events. Phosphorylation at Thr500 in the activation loop, the autophosphorylation site at Thr641, and at carboxy-terminal hydrophobic site Ser660 occurs in vivo (2). Atypical PKC isoforms lack hydrophobic region phosphorylation, which correlates with the presence of glutamic acid rather than the serine or threonine residues found in more typical PKC isoforms. Either the enzyme PDK1 or a close relative is responsible for PKC activation. A recent addition to the PKC superfamily is PKCμ (PKD), which is regulated by DAG and TPA through its C1 domain. PKD is distinguished by the presence of a PH domain and by its unique substrate recognition and Golgi localization (6). PKC-related kinases (PRK) lack the C1 domain and do not respond to DAG or phorbol esters. Phosphatidylinositol lipids activate PRKs and small Rho-family GTPases bind to the homology region 1 (HR1) to regulate PRK kinase activity (7).

    1. Nishizuka, Y. (1984) Nature 308, 693-698.
    2. Keranen, L.M. et al. (1995) Curr. Biol. 5, 1394-1403.
    3. Mellor, H. and Parker, P.J. (1998) Biochem J. 332 (Pt 2), 281-292.
    4. Ron, D. and Kazanietz, M.G. (1999) FASEB J. 13, 1658-1676.
    5. Moscat, J. and Diaz-Meco, M.T. (2000) EMBO Rep. 1, 399-403.
    6. Baron, C.L. and Malhotra, V. (2002) Science 295, 325-328.
    7. Flynn, P. et al. (2000) J. Biol. Chem. 275, 11064-11070.
    Application References

    Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know !

    Companion Products

    For Research Use Only. Not For Use In Diagnostic Procedures.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥3662
    北京智杰方远科技有限公司
    2025年07月16日询价
    ¥4420
    杭州囊萤科技有限公司
    2025年06月30日询价
    询价
    美国CST中国公司(丁香通商铺)
    2024年08月18日询价
    询价
    上海抚生实业有限公司
    2025年07月11日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月02日询价
    Phospho-PKC (pan) (gamma Thr514) Antibody
    询价